Undergraduate education

University of Wisconsin-Madison, BS, 1997

Years in MSTP

1998-2006

PhD

Molecular and cellular pharmacology, 2004

Mentor

Deane Mosher, MD

Thesis title

Structural Characterization of a Polymorphism in Thrombospondin-1 Associated with Familial Premature Coronary Atrtery Disease

Residency

Medicine, University of Wisconsin-Madison

Fellowship

Biochemistry, University of Wisconsin-Madison

Current position

Associate researcher, Department of Oncology, University of Wisconsin-Madison, School of Medicine and Public Health

PhD publications

Margosio B, Rusnati M, Bonezzi K, Cordes BL, Annis DS, Urbinati C, Giavazzi R, Presta M, Ribatti D, Mosher DF, Taraboletti G. Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain. Int J Biochem Cell Biol. 2008;40(4):700-9. PMID: 17996481; PMCID: PMC2346532.

Carlson CB, Bernstein DA, Annis DS, Misenheimer TM, Hannah BL, Mosher DF, Keck JL. Structure of the calcium-rich signature domain of human thrombospondin-2. Nat Struct Mol Biol. 2005 Oct;12(10):910-4. PMID: 16186819; PMCID: PMC2219892.

Hannah BL, Misenheimer TM, Pranghofer MM, Mosher DF. A polymorphism in thrombospondin-1 associated with familial premature coronary artery disease alters Ca2+ binding. J Biol Chem. 2004 Dec 10;279(50):51915-22. PMID: 15456750.

Misenheimer TM, Hannah BL, Annis DS, Mosher DF. Interactions among the three structural motifs of the C-terminal region of human thrombospondin-2. Biochemistry. 2003 May 6;42(17):5125-32. PMID: 12718556.

Hannah BL, Misenheimer TM, Annis DS, Mosher DF. A polymorphism in thrombospondin-1 associated with familial premature coronary heart disease causes a local change in conformation of the Ca2+-binding repeats. J Biol Chem. 2003 Mar 14;278(11):8929-34. PMID: 12643280.